Yes the ops move gives less risk to the sp, and makes the company more attractive as a T/O also makes it more attractive to Board purchasing stock prior to an announcement!
Trial results have had a high degree of variability thats very true and have bee done on to small a sample IMHO but the nano market cap is small for a company at this stage of devpt
They should not worry about FDA approval instead go the European route dueto the plant based product liked by German pharmacies
I would be hesitant about holding too much in this as it is extremely speculative so many wonder cancer treatment companies out there!
- Forums
- ASX - By Stock
- SBP
- agm today
SBP
solbec pharmaceuticals limited
agm today, page-9
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online